Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma

Cancer stem cells (CSCs) have been shown to accelerate tumor recurrence, radiotherapy, and chemotherapy resistance. Immunotherapy is a powerful anticancer treatment that can significantly prolong the overall survival of patients with lung adenocarcinoma (LUAD). However, little is known about the fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hongjie, Han, Linzhi, Zhao, Jinping, Wang, Kaijie, Xu, Ming, Shi, Jiajun, Dong, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683560/
https://www.ncbi.nlm.nih.gov/pubmed/34741449
http://dx.doi.org/10.1002/cam4.4377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683560/
https://www.ncbi.nlm.nih.gov/pubmed/34741449
http://dx.doi.org/10.1002/cam4.4377

Ejemplares similares